In today's episode, we delve into the groundbreaking $600 million funding round for Isomorphic Labs, a Google DeepMind spin-off. This investment marks a pivotal moment in AI-driven drug discovery, highlighting the potential of artificial intelligence to transform the pharmaceutical industry. Join us as we explore how Isomorphic Labs plans to utilize this funding to advance their AI drug design platform and the broader implications for AI in scientific research.

Sources:
https://tech.eu/2025/03/31/isomorphic-labs-nets-600m-in-first-external-funding-round/
https://www.prnewswire.com/news-releases/isomorphic-labs-announces-600-million-funding-to-further-develop-its-next-generation-ai-drug-design-engine-and-advance-therapeutic-programs-into-the-clinic-302415534.html
http://www.thepharmaletter.com/isomorphic-labs-announces-600-million-dollar-funding
https://www.genengnews.com/topics/artificial-intelligence/deepmind-spinout-isomorphic-labs-raises-600m-toward-ai-drug-design/
https://www.finsmes.com/2025/03/isomorphic-labs-raises-600m-in-funding.html
https://www.biocentury.com/article/655523/isomorphic-s-600m-funding-among-four-megarounds-finance-report
https://www.ddw-online.com/isomorphic-labs-raises-600m-to-support-ai-drug-design-34394-202504/
https://www.instagram.com/tradedvc/p/DH8kpQ2RnqB/isomorphic-labs-the-ai-drug-discovery-platform-spun-out-of-deepmind-in-2021-has-/
https://www.biopharmadive.com/news/isomorphic-venture-raise-alphabet-ai-drug-discovery/743983/

Ver todos los episodios